美国BD公司的动态

"Exploring the Future of Medicine: My Review on Co-Crystals in Novel Drug Delivery Systems. Discover how co-crystals are revolutionizing drug formulation and bioavailability. #Pharmaceuticals #DrugDelivery #Innovation

Mastering Nitrosamine Control in Pharma! Detecting and controlling potentially harmful #nitrosamine impurities in pharmaceuticals is no easy feat. Why? Because these impurities can form at any stage of the drug development pipeline. Our latest blog features an expert interview with Elizabeth Tocce, lead application scientist at IFF Pharma Solutions, who dives deep into the nitrosamine mitigation landscape. Discover: - Key questions to ask when developing your mitigation strategy - Innovative approaches using low nitrite #excipients to minimize nitrosamine risk - Expert tips for seamlessly integrating low nitrite excipients into your mitigation plan Read the full interview here – https://lnkd.in/gwKQrM_k #IFFPharma #Pharmaceuticals #DrugSafety

The future of #biopharma is bright, but it requires bold changes. Veeva’s 2025 predictions blog captures what’s ahead, including Ashley McMillan insights into the unification of QA and QC to eliminate bottlenecks and accelerate batch release. Take a moment to read the blog:?https://lnkd.in/gxZB2rAf And dive deeper into these topics at Veeva’s R&D Summit, register now:?https://lnkd.in/gMrPJrb8 #lifesciences #pharmaceuticals #quality

HealthVerity introduces taXOnomy?, the nation's most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research LINK: https://lnkd.in/dgU_jHmJ Hashtags: #TodaysMedicalUpdate #Pharmaceutical #Medical #Research Please LIKE & REPOST

In 2025, R&D and quality teams will focus on process excellence to overcome bottlenecks and drive faster, safer, and more efficient drug development. Veeva’s R&D experts make 8 #lifesciences predictions for the year ahead: https://bit.ly/3ZCZyvo #pharmaceuticals #biotechnology #drugdevelopment

In 2025, unifying QA and QC will transform batch release, eliminating bottlenecks and accelerating time-to-market. Veeva’s predictions highlight how connected data and streamlined workflows will drive efficiency and innovation in quality management. Check out the blog for insights or learn more by joining us at Veeva R&D Summit, register here: https://lnkd.in/eXXqhRGQ #lifesciences #pharamceuticals #batchrelease

How can pharmaceutical industry leaders navigate regulatory challenges to effectively harness the benefits of Industry 4.0 technologies? The industry's regulatory framework is heavily influenced by the complex nature of biological processes, the imperative of minimal operational errors, and the profound impact on patient health and safety. Additionally, the limited body of comprehensive scientific research on implementing Industry 4.0 technologies poses significant challenges. These hurdles include the need for extensive revalidation and regression testing of systems and conducting thorough impact analyses for sophisticated software. Let’s discuss how industry leaders can effectively navigate these regulatory waters to harness the benefits of Industry 4.0 technologies. Discover Part 5 of our 6 Barriers to Digital Transformation series now! #DigitalTransformation #Industry40 #Pharma #Biophorum #Pharmaceutical #Biopharma?

Recent insights reveal a strong optimism among executives, with 75% anticipating revenue growth and margin expansion. Here are some key predictions that could shape our future: Digital Transformation: The adoption of generative AI (GenAI) is set to revolutionize operations, with 60% of leaders planning to increase their investments in this technology. Focus on Process Excellence: R&D teams will prioritize process excellence to eliminate bottlenecks, driving faster, safer, and more efficient drug development. Personalized Medicine: Advances in genomics and biomarkers are paving the way for tailored treatments that enhance efficacy and minimize side effects. Navigating Regulatory Challenges: While patent expirations may pose challenges, innovation is expected to thrive, bolstered by AI-driven productivity enhancements. New Engagement Models: The industry will evolve new engagement strategies to simplify complex processes, ensuring healthcare professionals have quick access to vital information. Let’s embrace these changes and collaborate for a brighter future in life sciences! ??#LifeSciences #DrugDevelopment #DigitalTransformation #AI #Innovation #PersonalizedMedicine #Healthcare #ProcessExcellence #Pharma

HealthVerity introduces taXOnomy?, the nation's most comprehensive closed (X) and open (O) claims dataset for pharmaceutical research LINK: https://lnkd.in/d4iNcmhB Hashtags: #TodaysMedicalUpdate #Pharmaceutical #Medical #Research Please LIKE & REPOST

Excited to share our newly published review article in which we presented a unique perspective on sustainability of pharmaceutical cocrystals, showcasing their immense potential as an eco-friendly alternative to traditional solid forms for development of novel and improved drug products. By choosing representative case studies, we highlighted the ways in which pharmaceutical cocrystals make a positive impact towards sustainable drug development. These include dose reduction by improving drug bioavailability, minimizing environmental impact of toxic degradants by improving the stability of pharmaceutical actives, use of continuous and solvent-free manufacturing methods, and leveraging existing safety data of the APIs and pharmaceutically approved chemicals. Hope the article makes a valuable contribution to advance the growing knowledge on pharmaceutical cocrystals! Sincere thanks to anonymous reviewers for their time and providing valuable and constructive feedback on the manuscript and my co-author, Geetha Bolla, for her inputs and collaboration on this project. #Cocrystals #Sustainability #Pharmaceuticals